Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.830
-0.100 (-5.18%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Cellectis Revenue

Cellectis had revenue of $9.50M in the quarter ending June 30, 2024, with 374.91% growth. This brings the company's revenue in the last twelve months to $19.64M, down -20.70% year-over-year. In the year 2023, Cellectis had annual revenue of $9.19M, down -64.26%.

Revenue (ttm)
$19.64M
Revenue Growth
-20.70%
P/S Ratio
n/a
Revenue / Employee
$88,846
Employees
221
Market Cap
188.77M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 202059.56M36.57M159.09%
Dec 31, 201922.99M1.56M7.27%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Adaptimmune Therapeutics 141.46M
NeuroPace 71.82M
Semler Scientific 61.74M
Electromed 54.72M
MediWound 20.14M
Vaxart 13.93M
Atai Life Sciences 378.00K
Revenue Rankings